Australia’s child vaccination coverage is world-leading. Our adult coverage is not. Heightened vaccine hesitancy, misinformation, and disinformation following the COVID-19 pandemic has compounded existing challenges. Renewed focus and commitment are required to boost adult vaccination rates and protect the health of Australians.
Vaccine-preventable disease (VPD, a disease that can be prevented or have its severity reduced through vaccination) is a leading cause of avoidable hospitalisation in adults and costs the healthcare system billions each year. Lung Foundation Australia focus our efforts on five VPD that are caused by respiratory infections (COVID-19, influenza, pneumococcal disease, whooping cough, and respiratory syncytial virus [RSV]).
In 2024, we surveyed over 3,300 Australians to better understand barriers to adult vaccination, information needs, and support for potential policy measures. Respondents indicated strong support for increased government action, a desire for clear, individualised information, and simpler, more accessible, vaccine administration.
This technical report provides vaccination information and presents the survey method and results. It provides new data for policymakers and will guide Lung Foundation Australia’s vaccination advocacy. The technical report can be read in conjunction with the summary advocacy report that details our recommendations to the Australian Government for improving adult vaccination coverage.
Lung Foundation Australia affirm that vaccination against respiratory infection is vital to protect the lung health of Australians living with, and without, lung disease. We will continue to advocate for change that improves lung health and reduces the impact of lung disease.
Lung Foundation Australia’s vaccination survey and this report were supported by funds from GSK Australia, Moderna Australia, and Sanofi Australia. These companies were not involved in survey administration, or in the development, review or editing of this report.
We thank the survey respondents from our lung disease community, and from the Australian public, for sharing their experiences and insights. Your responses will guide Lung Foundation Australia’s advocacy to improve adult vaccination coverage.
Was this page helpful?
Good job! Please give your positive feedback
How could we improve this post? Please Help us.
